Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study
- PMID: 24444445
- PMCID: PMC4219255
- DOI: 10.1016/j.hrthm.2014.01.018
Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study
Abstract
Background: MicroRNA (miRNA) expression in atrial tissue has been implicated in pathologic susceptibility to atrial fibrillation (AF). Nevertheless, data on how circulating levels relate to AF are limited.
Objective: The purpose of this study was to test the hypothesis that circulating miRNAs are associated with AF.
Methods: Among 2445 Framingham Heart Study Offspring participants, we measured the expression of 385 circulating whole blood miRNAs by high-throughput quantitative reverse transcriptase polymerase chain reaction. We related miRNA levels with prevalent and new-onset AF.
Results: Mean age of the cohort was 66.3 ± 8.9 years, and 56% were women; 153 participants had clinically apparent AF at baseline, and 107 developed AF during median follow-up of 5.4 years. miRNA-328 (miR-328) expression was lower among participants with prevalent AF (8.76 cycle threshold) compared to individuals with no AF (7.75 cycle threshold, P <.001). The association between miR-328 and prevalent AF persisted after adjustment for age, sex, and technical covariates (odds ratio 1.21, P = 1.8 × 10(-4)) but was attenuated in analyses adjusting for clinical AF risk factors (odds ratio 1.14, P = .017). In contrast to the associations between miR-328 and prevalent AF, none of the circulating miRNAs were associated with incident AF.
Conclusion: Circulating levels of miR-328, a miRNA known to promote atrial electrical remodeling by reducing L-type Ca(2+) channel density, were associated with prevalent AF. Adjustment for risk factors that promote atrial remodeling, including hypertension, attenuated the association between miR-328 and AF, potentially implicating miR-328 as a potential mediator of atrial remodeling and AF vulnerability.
Keywords: Atrial fibrillation; Circulation; Epidemiology; Risk factors; microRNA.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA. 2001;285:2370–2375. - PubMed
-
- Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125. - PubMed
-
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The framingham study. Stroke. 1991;22:983–988. - PubMed
-
- Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The framingham heart study. Circulation. 2003;107:2920–2925. - PubMed
-
- Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The framingham heart study. JAMA. 1994;271:840–844. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS017950/NS/NINDS NIH HHS/United States
- UH3 TR000921/TR/NCATS NIH HHS/United States
- R01 HL087201/HL/NHLBI NIH HHS/United States
- U01 HL105268/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01HL087201A/HL/NHLBI NIH HHS/United States
- KL2 RR031981/RR/NCRR NIH HHS/United States
- 6R01-NS17950/NS/NINDS NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- KL2RR031981/RR/NCRR NIH HHS/United States
- R01 HL064753/HL/NHLBI NIH HHS/United States
- 1U01HL105268-01/HL/NHLBI NIH HHS/United States
- RFA-HL-12-008/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- UH2 TR000921/TR/NCATS NIH HHS/United States
- U54 HL112311/HL/NHLBI NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
- 1R01HL64753/HL/NHLBI NIH HHS/United States
- 1R01AG028321/AG/NIA NIH HHS/United States
- N01-HC25195/HC/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources